Lv6
2020 积分 2022-09-21 加入
Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells
28天前
已完结
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
28天前
已完结
Unlocking the Next Frontier in Precision Oncology: Addressing Drug-Tolerant Residual Disease
28天前
已完结
The Cell Cycle: a Key to Unlock EZH2-targeted Therapy Resistance
28天前
已完结
Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy
28天前
已完结
Discovery of Orally Bioavailable and Potent CDK9 Inhibitors for Targeting Transcription Regulation in Triple-Negative Breast Cancer
1个月前
已关闭
Comparing development strategies for PD1/PDL1-based immunotherapies
1个月前
已完结
Therapeutic compounds targeting interleukin-1 receptor-associated kinase 4 (IRAK4): an updated patent review (2019 to present)
1个月前
已完结
A patent review of MALT1 inhibitors (2013-present)
1个月前
已完结
Pharmacology in Drug Discovery and Development: Understanding Drug Response, Third Edition • 2024
2个月前
已完结
皖公网安备34019202002308
